Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Operating Expenses (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Operating Expenses for 2 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 50.49% to $15.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.1 million through Dec 2025, up 19.91% year-over-year, with the annual reading at $58.1 million for FY2025, 19.91% up from the prior year.
  • Operating Expenses hit $15.5 million in Q4 2025 for Connect Biopharma Holdings, down from $17.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $17.7 million in Q3 2025 to a low of $10.3 million in Q4 2024.